Advertisement

Topics

The Association for Molecular Pathology (AMP) Company Profile

22:16 EDT 22nd June 2018 | BioPortfolio

The Association for Molecular Pathology (AMP) was founded in 1995 to provide structure and leadership to the emerging field of molecular diagnostics. Through the efforts of its Board of Directors, Committees, Working Groups, and members, AMP is the primary resource for expertise, education, and collaboration on the fastest growing fields in healthcare. AMP members influence policy and regulation on the national and international levels, ultimately serving to advance innovation in the field and protect patient access to high quality, appropriate testing. More information about AMP is available at www.amp.org.


News Articles [1083 Associated News Articles listed on BioPortfolio]

Leading medical organizations update lung cancer guideline

(International Association for the Study of Lung Cancer) Rapid advancements in the molecular diagnostic testing of lung cancer have led to new treatments and greater hope for patients battling lung ca...

Deploying Digital Pathology in the Autopsy Service Before Surgical Pathology

I believe that most pathology teaching programs in the U.S. will be feeling a need to launch a digital pathology program soon because pathology house officer and fellow candidates are favoring those p...

AMP publishes recommendations for clinical CYP2C19 genotyping allele selection

(Association for Molecular Pathology) AMP has published consensus, evidence-based recommendations to aid clinical laboratory professionals when designing and validating clinical CYP2C19 assays, promot...

Updated guideline for molecular testing and targeted therapies in lung cancer

(Brigham and Women's Hospital) A panel of leading experts in molecular pathology has issued new recommendations and updates to guidelines for molecular diagnostic testing of patients with lung cancer....

[Comment] Pathology and laboratory medicine: the Cinderella of health systems

High-quality pathology and laboratory medicine (PALM) services are an integral part of health systems in high-income countries. New molecular diagnostic techniques, advances in precision cancer treatm...

Molecular classification in brain tumours

Dr Gilbert talks to ecancer at the Cancer Research UK Brain Tumour Conference 2018 in London about the use of molecular classification in brain tumours and whether classical pathology supersedes it. ...

Experts issue updated guidelines for molecular diagnostic testing of patients with lung cancer

A panel of leading experts in molecular pathology has issued new recommendations and updates to guidelines for molecular diagnostic testing of patients with lung cancer.

Pathology Informatics Webinar on Precision Medicine; February 20 at 1:00 p.m. ET

You are all invited to participate in an upcoming free webinar entitled: The Challenges of Enabling Precision Medicine Diagnostics. This is part of a continuing series of presentations sponsored by th...

PubMed Articles [3202 Associated PubMed Articles listed on BioPortfolio]

HER2 testing of gastro-oesophageal adenocarcinoma: a commentary and guidance document from the Association of Clinical Pathologists Molecular Pathology and Diagnostics Committee.

The use of biologics targeted to the human epidermal growth factor receptor 2 (HER2) protein is the latest addition to the armamentarium used to fight advanced gastric or gastro-oesophageal junction a...

Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement Summary of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline Update.

Recommendations for Clinical CYP2C19 Genotyping Allele Selection: A Report of the Association for Molecular Pathology.

This document was developed by the Pharmacogenetics (PGx) Working Group of the Association for Molecular Pathology (AMP) Clinical Practice Committee, whose aim is to recommend variants for inclusion i...

LINC00511 interacts with miR-765 and modulates tongue squamous cell carcinoma progression by targeting LAMC2.

Aimed at underlying the molecular regulatory mechanism and overall biological functions of LINC00511 in tongue squamous cell carcinoma (TSCC).

Evidence-based dentistry: Challenges and possibilities.

Clinical Trials [3319 Associated Clinical Trials listed on BioPortfolio]

Lung Allograft Rejection Gene Expression Observational (LARGO) Study

The objective of the LARGO Study protocol is to collect peripheral blood samples, select associated lung biopsy pathology slides, and clinical data from lung transplant recipients to perfo...

Molecular Pathology of Colorectal Cancer: Investigating the Role of Novel Molecular Profiles, microRNA's, and Their Targets in Colorectal Cancer Progression

Molecular pathology of Colorectal Cancer: Investigating the role of novel molecular profiles, microRNA's and their targets in Colorectal Cancer progression

iMarkHD: In Vivo Longitudinal Imaging of HD Pathology

iMarkHD is an innovative clinical imaging study and collaboration between the CHDI Foundation and Professor Marios Politis from King's College London (KCL) designed to assess longitudinal ...

Mutation Analysis of 17α-Hydroxylase

To elucidate the molecular pathology of the 4 families with 17α-hydroxylase/17,20-lyase deficiency.

Mutation Analysis of 17βhydroxysteroid Dehydrogenase 3 Deficiency

To disclose the molecular pathology of our 3 families with 17βHSD3 deficiency.

Companies [2264 Associated Companies listed on BioPortfolio]

The Association for Molecular Pathology (AMP)

The Association for Molecular Pathology (AMP) was founded in 1995 to provide structure and leadership to the emerging field of molecular diagnostics. Through the efforts of its Bo...

Association for Molecular Pathology (AMP)

The Association for Molecular Pathology (AMP) was founded in 1994 to provide structure and leadership to what was, at the time, the newly‐emerging field of molecular diagnost...

Lakewood Pathology Associates

Lakewood Pathology Associates (LPA) is a national anatomical pathology company providing comprehensive and dynamic pathology services tailored to the outpatient needs of surgeons of diverse specialtie...

HistoRx, Inc

HistoRx is a bioscience company applying quantitative tools of molecular and cellular biology to develop new tools for pathology.HistoRx has introduced the first tissue-based quantitative molecular as...

RedPath Integrated Pathology, Inc.

RedPath Integrated Pathology, Inc. is a US cancer molecular diagnostics company that provides comprehensive molecular analysis to resolve challenging diagnostic dilemmas. The comp...

More Information about "The Association for Molecular Pathology (AMP)" on BioPortfolio

We have published hundreds of The Association for Molecular Pathology (AMP) news stories on BioPortfolio along with dozens of The Association for Molecular Pathology (AMP) Clinical Trials and PubMed Articles about The Association for Molecular Pathology (AMP) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Association for Molecular Pathology (AMP) Companies in our database. You can also find out about relevant The Association for Molecular Pathology (AMP) Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record